| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |